Glaxo-Smith Kline, Hoechst Marion Roussel, Hoffman LaRoche, Janssen-Ortho, Oscient Pharmaceuticals, Merck Frosst, Pfizer, Rhone-Poulenc Rorer, Smith-Kline Beecham, Wyeth-Ayerst, YM Biosciences ...

Glaxo Smith Kline (GSK). The curriculum is heavily informed by industry representatives who sit on an advisory board within the School. The School has a wide range of high end workstations, ...

The trial testing the immune response of co-administration of GSK's blockbuster vaccines, Shingrix and Arexvy, in adults over ...

Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

Smith joined me for a conversation on my podcast. This is an edited transcript of part of our conversation. For the full conversation, listen to “The Ezra Klein Show.” Please note this episode ...

This summer, GSK cut its yearly vaccine sales projection on the back of a narrowed recommendation for adult respiratory syncytial virus (RSV) vaccines from the Centers for Disease Control and ...

GSK has turned to Brooke Shields to get the message out about shingles vaccination. The drugmaker has worked with the model and actor to talk to female celebrities and patients aged 50 years and ...

British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles ...

GSK (NYSE:GSK) announced Wednesday that its Arexvy vaccine for respiratory syncytial virus (RSV) and its Shingrix vaccine for ...

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.